Skip to content

A RCT for Y-Knot All-suture Anchor in Ankle Ligaments Injury Repair

A Multi-center, Randomized Controlled Trial to Evaluate the Effectiveness and Safety of Y-Knot All-suture Anchor in Ankle Ligaments Injury Repair

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04310956
Enrollment
148
Registered
2020-03-17
Start date
2019-12-23
Completion date
2021-12-01
Last updated
2022-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ligament Injury

Brief summary

Purpose of this study is to evaluate the effectiveness and safety of Y-Knot all-suture anchor by comparing patients' clinical outcome after ankle ligaments repair surgery.

Interventions

DEVICEY-Knot all-suture anchor

Y-knot all-suture anchor will be implanted to participants

DEVICEBiocomposite suture anchor

Biocomposite suture anchor will be implanted to participants

Sponsors

ConMed Linvatec Beijing
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or Female, no less than 18 years old; * Patient was diagnosed as Collateral Ligament injury or Achilles tendon injury based on MRI or X-Ray who need to conduct foot&ankle repair surgery by investigator; * Patient willing to sign a written consent form participating in this study; * Subject is able to understand study, willing to comply the study procedures, and willing to return to hospital for follow-up up to 6 months postoperative; * Life expectancy is more than 2 years post-operationally;

Exclusion criteria

* Conducted surgery at index ankle and possibly influence the outcome evaluation; * Bilateral ankle surgery; * Suffering concurrent ankle disease that may leads to a surgery during the study phase; * known or suspected allergies to implant and/or instrument materials; * pathological conditions of bone which would adversely affect the anchor fixation; with concurrent severe injury at index leg that may influence the outcome evaluation; Severe obesity; * With concurrent disease that may influence the index ankle function; * Patients with active sepsis or infection; * With concurrent disease that may influence the stability of device and rehabilitation; * Immune suppression, impairment of immune function, or autoimmune disease; * Pregnant or lactating women; * Known noncompliance or lost follow-up risk; * Participated other drug, biologic, or device clinical trial 12 months before enrollment; * Alcohol or drug abuser; * Other inappropriate condition based on investigator determination;

Design outcomes

Primary

MeasureTime frame
improvement of AOFAS scoreFrom pre-operation to 6 months postoperative

Secondary

MeasureTime frame
improvement of AOFAS scoreFrom pre-operation to 3 months postoperative
Improvement of VAS scoreFrom pre-operation to 3 and 6 months postoperative
ligament injury recurrencesup to 6 months postoperative
secondary surgeryup to 6 months postoperative

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026